ArticleEvidence-based medicine2011

Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity.

Jean-François Turcotte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.